June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
The TGFβ co-receptor betaglycan (TGFBR3) is not implicated in TGFβ-dependent T-cell responses
Author Affiliations & Notes
  • Robert John Barry
    Academic Unit of Ophthalmology, University of Birmingham, Birmingham, United Kingdom
    Centre for Translational Inflammation Research, University of Birmingham, Birmingham, United Kingdom
  • David Withers
    Institute of Biomedical Research, University of Birmingham, Birmingham, United Kingdom
  • Graham R Wallace
    Academic Unit of Ophthalmology, University of Birmingham, Birmingham, United Kingdom
    Centre for Translational Inflammation Research, University of Birmingham, Birmingham, United Kingdom
  • Peter Lane
    Institute of Biomedical Research, University of Birmingham, Birmingham, United Kingdom
  • Philip Ian Murray
    Academic Unit of Ophthalmology, University of Birmingham, Birmingham, United Kingdom
    Centre for Translational Inflammation Research, University of Birmingham, Birmingham, United Kingdom
  • John Curnow
    Academic Unit of Ophthalmology, University of Birmingham, Birmingham, United Kingdom
    Centre for Translational Inflammation Research, University of Birmingham, Birmingham, United Kingdom
  • Footnotes
    Commercial Relationships Robert Barry, None; David Withers, None; Graham Wallace, None; Peter Lane, None; Philip Murray, None; John Curnow, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 849. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Robert John Barry, David Withers, Graham R Wallace, Peter Lane, Philip Ian Murray, John Curnow; The TGFβ co-receptor betaglycan (TGFBR3) is not implicated in TGFβ-dependent T-cell responses. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):849.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Transforming Growth Factor-β (TGFβ) is considered an important immunoregulatory cytokine. In experimental models of uveitis, TGFβ, in the presence of pro-inflammatory co-stimulatory molecules, drives differentiation of naïve CD4+ T-cells to a pathogenic Th17 phenotype. TGFβ exists in three isoforms and signals through a receptor comprising three subunits. The role of TGFBR1 and 2 is well characterized but the function of TGFBR3 (betaglycan) is unclear. Betaglycan is implicated in embryogenesis, carcinogenesis, and intrathymic T-cell development, but its role in peripheral immune responses is unknown. Betgalycan is considered necessary to present TGFβ2, but not the other isoforms, to the TGFBR1/2 receptor complex and may be important in environments where TGFβ2 predominates, such as the eye. Our aim was to examine the role of betaglycan in controlling T-cell responses to TGFβ.

Methods: Homozygous betaglycan deficiency is embryonic lethal; we therefore generated fetal liver chimeras in rag-deficient mice to create a model in which all T and B-cells lack betaglycan. We phenotyped this model, performed controlled antigenic challenge in vivo to assess Th1, Treg and Th17 responses, and created naive T-cell differentiation assays in vitro to assess FoxP3 induction by all isoforms of TGFβ.

Results: Betaglycan-deficient mice showed reconstitution of peripheral lymphocyte populations within 6 weeks of cell transfer. We observed sporadic immune activation in betaglycan-deficient mice, demonstrated by increased proportions of effector CD4+ and CD8+ T-cells in circulating, lymph node and splenocyte populations. We have found no evidence of circulating serum autoantibodies. No significant difference was observed between betaglycan-deficient and wild-type chimeras in response to antigenic challenge by attenuated Listeria monocytogenes, incomplete Freund's adjuvant or bacterial porins. All isoforms of TGFβ induced FoxP3 expression in naïve CD4+ T-cells with no significant difference between cells derived from betaglycan-deficient and wild-type chimeras.

Conclusions: We have created a novel experimental model in which to assess the role of betaglycan on mature T-cell responses. In contrast to its role in other areas, betaglycan appears unnecessary for TGFβ-dependent T-cell responses in our assays. Further work is required to assess betaglycan function in environments where TGFβ2-driven T-cell responses predominate.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×